Immune-Onc Therapeutics is a startup based in the United States, 1 tracked investor.
Immune-Onc Therapeutics is a startup based in the United States. Brouky records 1 investor associated with the company.
Immune-Onc Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies that target myeloid cells to treat blood cancers, solid tumors, and autoimmune diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.